BMS 303141 is a cell-permeable, 2-hydroxy-N-arylbenzenesulfonamide that inhibits ACL with an IC50 value of 0.13 µM. BMS 303141 has been reported to reduce weight gain and lower plasma cholesterol, triglycerides, and glucose in a mouse model of hyperlipidemia. Source summary: BMS303141 research chemical for biochemical studies; small-molecule modulator for target pathway research and laboratory use.
Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | ATP Citrate Lyase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye